GNMX vs IBBQ: Grades, Fees and Holdings Compared

Corgi Genomics & Precision Medicine ETF

GNMXCCboe

Invesco Nasdaq Biotechnology ETF

IBBQANasdaq

Overlap

31.0%by weight

Expense ratio

IBBQ −0.16pt a year

GNMX0.35%IBBQ0.19%

Avg volume · 30D

IBBQ 20.5×the volume

GNMX1.79KIBBQ36.6K

GNMX vs IBBQ Performance

Jul 31, 2026 – Oct 30, 2026

+28.1%GNMX+13.4%IBBQ

Expense ratio: GNMX 0.35%; IBBQ 0.19%, better
Fund size: GNMX $1M; IBBQ $120M
1Y total return: GNMX No data; IBBQ +37.1%
Yield (12M): GNMX No data; IBBQ 1.08%
Holdings: GNMX 58; IBBQ 250
Avg volume (30D): GNMX 1.79K sh; IBBQ 36.6K sh, better
NAV per share: GNMX $38.06; IBBQ $36.17
52W range

ETF.net Grade

Pillar letters and Scores for GNMX, IBBQ, with each pillar’s weight
Pillar	GNMX	IBBQ
Cost30% weight	A81	A100Higher
Mission25% weight	Not scored	A84
Risk15% weight	A71	A73Higher
Tradability15% weight	F17	C48Higher
Holdings10% weight	C49	B62Higher
Durability5% weight	F0	C42Higher

Rank among Biotech & Genomics funds

How we build Categories ›

Same Category. GNMX and IBBQ are both graded against the same 17 Biotech & Genomics funds, so their Grades compare head to head.

Biotech & Genomics⁠

Category · 17 funds

See all 17 ›

IBBQ ranks 2nd and GNMX 11th of 17 funds in the Biotech & Genomics Category.

Rank 1AXBIState Street SPDR S&P Biotech ETFScore 80
Rank 2AIBBQInvesco Nasdaq Biotechnology ETFScore 77
Rank 3AIBBiShares Biotechnology ETFScore 75
Rank 10CIBRNiShares Neuroscience and Healthcare ETFScore 43
Rank 11CGNMXCorgi Genomics & Precision Medicine ETFScore 40
Rank 11CWDNAWisdomTree BioRevolution FundScore 40

Our read on each fund

ETF.net Research

GNMXCCorgi Genomics & Precision Medicine ETF

IBBQAInvesco Nasdaq Biotechnology ETF

In short

GNMX No data

IBBQ The broad Nasdaq biotech benchmark, bought cheap. IBBQ tracks the whole listed biotech and pharma field, roughly 300 names, for 0.19% a year, well under half the typical fee in its category.

Stated mandate

GNMX No data

IBBQ The Fund tracks the Nasdaq Biotechnology Index and normally invests at least 90% of its assets in index constituents. The index covers Nasdaq-listed companies classified as biotechnology or pharmaceutical companies.

Why people hold it

GNMX No data

IBBQ At 0.19% a year, the lowest fee among its closest biotech rivals and less than half the category median.
Holds roughly 300 Nasdaq-listed biotech and pharma companies, so one failed trial or one blockbuster is a slice of the fund, not the whole story.invesco.com
Rules first: normally at least 90% of assets sit in Nasdaq Biotechnology Index constituents. No manager guessing which pipeline pays off.invesco.com
Stands in the top quartile of the biotech and genomics funds we grade, keeping company with far larger rivals like XBI and IBB.

Worth knowing

GNMX No data

IBBQ Thinly traded next to the category's giants, so bid-ask spreads can widen. Limit orders matter more here than in a heavily traded fund.
One sector, and a jumpy one: biotech and pharma prices move on trial data and regulatory decisions, a rougher ride than a broad-market fund.invesco.com
Launched in 2021, so a shorter live record and a smaller asset base than the category's long-standing funds.

Full GNMX profile⁠

Full IBBQ profile⁠

GNMX vs IBBQ Holdings

How GNMX and IBBQ differ

Overlap by weight

31.0%

Shared holdings make up 73.5% of GNMX and 32.6% of IBBQ.

Level by level

Holdings41 in both31.0%
Countryby domicile94.4%
Sector3 Sectors97.6%
Asset classEquity100%

Sector

Sector weights in GNMX and IBBQ, widest gap first
Sector	More in GNMXMore in IBBQ	GNMX	IBBQ
Technology	GNMX +2.4 points	2.4%	0.0%
Health Care	IBBQ +2.4 points	97.6%	100.0%
Financials	Same weight	0.0%	0.0%

Country, concentration and asset class

Country by domicile

Country weights in GNMX and IBBQ, widest gap first
Country	More in GNMXMore in IBBQ	GNMX	IBBQ
Denmark	GNMX +4.1 points	4.5%	0.4%
United States	IBBQ +2.5 points	92.7%	95.2%
United Kingdom	IBBQ +2.0 points	0.0%	2.0%
Switzerland	GNMX +0.9 points	1.3%	0.4%
Canada	IBBQ +0.5 points	0.0%	0.5%
Other countries (8)	IBBQ +0.2 points	1.5%	1.7%

Concentration

Weight in the 10 largest Holdings

GNMX48.2%
IBBQ47.2%

Securities held

GNMX58
IBBQ248

Asset class

GNMX: Equity
IBBQ: Equity

Holdings

Only in GNMX17
In both41
Only in IBBQ207

Only in GNMX

17 securities, 26.5% of GNMX by weight

Thermo Fisher Scientific Inc8.79%
First American Government Obligations Fund 12/01/20312.49%
CareDx Inc2.48%
Bio-Techne Corp2.10%
Qiagen NV2.06%
NeoGenomics Inc1.33%
Schrodinger Inc/United States1.30%
Certara Inc0.96%
Azenta Inc0.92%
GeneDx Holdings Corp0.73%
Generate Biomedicines Inc0.64%
Myriad Genetics Inc0.58%
Sophia Genetics SA0.57%
Biodesix Inc0.51%
Fulgent Genetics Inc0.51%
Precision BioSciences Inc0.28%
Standard Biotools Inc0.25%

Only in IBBQ

207 securities, 67.4% of IBBQ by weight

Gilead Sciences Inc8.81%
Amgen Inc8.35%
Regeneron Pharmaceuticals Inc5.27%
Biogen Inc2.35%
Royalty Pharma PLC1.87%
Roivant Sciences Ltd1.73%
United Therapeutics Corp1.62%
Insmed Inc1.55%
Argenx SE1.55%
Viatris Inc1.40%
Medpace Holdings Inc1.20%
Exelixis Inc1.04%
Ascendis Pharma A/S0.99%
Halozyme Therapeutics Inc0.95%
Neurocrine Biosciences Inc0.95%
Bridgebio Pharma Inc0.90%
Jazz Pharmaceuticals PLC0.86%
BeOne Medicines Ltd0.85%
Summit Therapeutics Inc0.82%
BioNTech SE0.66%
Kymera Therapeutics Inc0.65%
Madrigal Pharmaceuticals Inc0.63%
Protagonist Therapeutics Inc0.60%
Sanofi SA0.59%
Vaxcyte Inc0.59%
ImmunityBio Inc0.59%
Cytokinetics Inc0.56%
Spyre Therapeutics Inc0.55%
Praxis Precision Medicines Inc0.51%
Alkermes PLC0.49%
Axsome Therapeutics Inc0.48%
Amneal Pharmaceuticals Inc0.47%
Ligand Pharmaceuticals Inc0.41%
Rhythm Pharmaceuticals Inc0.41%
Oruka Therapeutics Inc0.41%
Kodiak Sciences Inc0.40%
Immunovant Inc0.39%
Mirum Pharmaceuticals Inc0.36%
CG oncology Inc0.36%
Cogent Biosciences Inc0.35%
Scholar Rock Holding Corp0.34%
PTC Therapeutics Inc0.34%
Erasca Inc0.33%
Definium Therapeutics Inc0.32%
Abivax SA0.32%
Travere Therapeutics Inc0.30%
Kiniksa Pharmaceuticals International Plc0.30%
AbCellera Biologics Inc0.27%
Edgewise Therapeutics Inc0.27%
Indivior Pharmaceuticals Inc0.26%

Weight gaps

All 41 Holdings in both funds, largest gap first.

Holding weights in GNMX and IBBQ, widest gap first
Holding	More in GNMXMore in IBBQ	GNMX	IBBQ
Genmab A/SGMAB	GNMX +4.21 points	4.56%	0.35%
Moderna IncMRNA	GNMX +4.00 points	9.67%	5.67%
10X Genomics IncTXG	GNMX +2.35 points	2.98%	0.63%
Guardant Health IncGH	GNMX +2.08 points	3.66%	1.58%
GRAIL IncGRAL	GNMX +1.81 points	2.26%	0.45%
Twist Bioscience CorpTWST	GNMX +1.76 points	2.49%	0.73%
Vertex Pharmaceuticals IncVRTX	IBBQ +1.56 points	6.17%	7.73%
Iovance Biotherapeutics IncIOVA	GNMX +1.53 points	1.81%	0.28%
Adaptive Biotechnologies CorpADPT	GNMX +1.36 points	1.65%	0.29%
Illumina IncILMN	GNMX +1.30 points	4.09%	2.79%
BioMarin Pharmaceutical IncBMRN	GNMX +1.23 points	1.94%	0.71%
Incyte CorpINCY	GNMX +1.15 points	2.66%	1.51%
Absci CorpABSI	GNMX +1.14 points	1.27%	0.13%
Krystal Biotech IncKRYS	GNMX +1.14 points	1.75%	0.61%
Veracyte IncVCYT	GNMX +1.12 points	1.39%	0.27%
Nurix Therapeutics IncNRIX	GNMX +1.09 points	1.27%	0.18%
Personalis IncPSNL	GNMX +1.07 points	1.18%	0.11%
CRISPR Therapeutics AGCRSP	GNMX +0.94 points	1.27%	0.33%
Tempus AI IncTEM	GNMX +0.91 points	1.78%	0.87%
Ideaya Biosciences IncIDYA	GNMX +0.84 points	1.04%	0.20%
Caris Life Sciences IncCAI	GNMX +0.79 points	1.44%	0.65%
uniQure NVQURE	GNMX +0.78 points	0.89%	0.11%
Recursion Pharmaceuticals IncRXRX	GNMX +0.76 points	0.90%	0.14%
Arrowhead Pharmaceuticals IncARWR	GNMX +0.74 points	1.29%	0.55%
Castle Biosciences IncCSTL	GNMX +0.74 points	0.82%	0.08%
Beam Therapeutics IncBEAM	GNMX +0.73 points	0.92%	0.19%
Relay Therapeutics IncRLAY	GNMX +0.70 points	0.97%	0.27%
Sarepta Therapeutics IncSRPT	GNMX +0.69 points	0.82%	0.13%
Pacific Biosciences of California IncPACB	GNMX +0.67 points	0.73%	0.06%
Ionis Pharmaceuticals IncIONS	GNMX +0.63 points	1.10%	0.47%
Intellia Therapeutics IncNTLA	GNMX +0.58 points	0.70%	0.12%
4D Molecular Therapeutics IncFDMT	GNMX +0.55 points	0.59%	0.04%
Revolution Medicines IncRVMD	GNMX +0.52 points	3.12%	2.60%
Prime Medicine IncPRME	GNMX +0.48 points	0.54%	0.06%
Ultragenyx Pharmaceutical IncRARE	GNMX +0.47 points	0.58%	0.11%
Arcturus Therapeutics Holdings IncARCT	GNMX +0.40 points	0.42%	0.02%
Solid Biosciences IncSLDB	GNMX +0.37 points	0.41%	0.04%
Editas Medicine IncEDIT	GNMX +0.30 points	0.33%	0.03%
Rocket Pharmaceuticals IncRCKT	GNMX +0.25 points	0.27%	0.02%
Alnylam Pharmaceuticals IncALNY	GNMX +0.25 points	1.73%	1.48%
Caribou Biosciences IncCRBU	GNMX +0.06 points	0.06%	<0.01%

All 30 GNMX holdings⁠All 247 IBBQ holdings⁠

How we measure overlap

Each holding counts at its smaller weight in the two funds, summed over the full Holdings. Sector, country and asset class use the same rule on each fund’s split. Cash, FX and derivative lines stay out of the counts. Two bond funds get no overlap figure.

GNMX vs IBBQ Cost

Overpaying GNMX vs IBBQ

$3,174

On $10,000 over 30 years. 7% growth a year before fees, expense ratio only.

GNMX 0.35%
$7,126
IBBQ 0.19%
$3,952

Amount$10,000

Years30 years

Cost over time

GNMX 0.35%
IBBQ 0.19%
Overpaying

Year by year

Year	GNMX	IBBQ	Overpaying
10	$634	$347	$287
20	$2,454	$1,351	$1,103
30	$7,126	$3,952	$3,174

Expense ratio

0.35%GNMX
0.19%IBBQ, cheaper

IBBQ0.19%GNMX0.35%

0.19%0.75%

Middle half of Biotech & Genomics funds
Median 0.47%

IBBQ cheapest of 17 funds

GNMX 3rd cheapest of 17 funds

GNMX vs IBBQ Dividends

Last 12 months to Oct 30, 2026

Yield (12M): GNMX No data; IBBQ 1.08%
Payout (12M): GNMX None; IBBQ $0.39
Last payment: GNMX No data; IBBQ $0.23
Ex-dividend: GNMX No data; IBBQ Sep 21, 2026
Paid on: GNMX No data; IBBQ Sep 25, 2026
Frequency: GNMX No data; IBBQ Quarterly

Distribution history

Per share, 2021 to 2026, same scale for both

GNMXAll GNMX payments⁠

No distribution history available.

IBBQQuarterly · 21 paymentsAll IBBQ payments⁠

GNMX vs IBBQ Risk

Fall from peak · 5 years

This chart needs five years of history for both funds.

Risk facts

VolatilityStd dev, 3 years: GNMX No dataIBBQ 16.8%
Return per unit of riskSharpe ratio, 3 years: GNMX No dataIBBQ 1.22
Worst fallMax drawdown, 5 years: GNMX No dataIBBQ −34.8%
Market sensitivityBeta, 5 years: GNMX 2.27IBBQ 0.61; Market = 1

Popular comparisons

GNMXCvsXBIA
Corgi Genomics & Precision Medicine ETF · State Street SPDR S&P Biotech ETF
Expense ratio
0.35% · 0.35%
Category
IBBQAvsXBIA
Invesco Nasdaq Biotechnology ETF · State Street SPDR S&P Biotech ETF
Expense ratio
0.19% · 0.35%
Category
GNMXCvsIBBA
Corgi Genomics & Precision Medicine ETF · iShares Biotechnology ETF
Expense ratio
0.35% · 0.44%
Category
IBBQAvsIBBA
Invesco Nasdaq Biotechnology ETF · iShares Biotechnology ETF
Expense ratio
0.19% · 0.44%
Category
GNMXCvsBBPA
Corgi Genomics & Precision Medicine ETF · Virtus Biotech ETF
Expense ratio
0.35% · 0.34%
Category
IBBQAvsBBPA
Invesco Nasdaq Biotechnology ETF · Virtus Biotech ETF
Expense ratio
0.19% · 0.34%
Category